Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04789096
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2021-03-01
Brief Title:
Tucatinib Together With Pembrolizumab and Trastuzumab
Sponsor:
Organization:
Breast Cancer Trials Australia and New Zealand